company background image
AMED logo

Amedisys NasdaqGS:AMED 株式レポート

最終価格

US$90.16

時価総額

US$2.9b

7D

-0.1%

1Y

-4.0%

更新

21 Nov, 2024

データ

会社財務 +

Amedisys, Inc.

NasdaqGS:AMED 株式レポート

時価総額:US$2.9b

AMED 株式概要

アメディシス・インクはその子会社とともに米国で医療サービスを提供している。 詳細

AMED ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長3/6
過去の実績3/6
財務の健全性6/6
配当金0/6

Amedisys, Inc. 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめAmedisys
過去の株価
現在の株価US$90.16
52週高値US$98.95
52週安値US$88.81
ベータ0.78
11ヶ月の変化-7.10%
3ヶ月変化-7.59%
1年変化-3.97%
33年間の変化-43.10%
5年間の変化-45.36%
IPOからの変化1,617.33%

最新ニュース

Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance

Nov 05

Recent updates

Final Push For Amedisys As UnitedHealth Awaits Regulatory Clearance

Nov 05

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Apr 10
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?

Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Feb 25
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?

Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

Feb 10
Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around

At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jan 03
At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Dec 16
A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Nov 12
Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal

Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

Sep 19
Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?

An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Sep 04
An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued

Amedisys: ROIC, Tangible Book Value Each Softening

Aug 24

Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Aug 04
Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement

Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates

Jul 27

We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

Jul 20
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt

At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Jun 04
At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?

Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

May 05
Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled

Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Apr 20
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?

Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Apr 06
Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?

Is Amedisys (NASDAQ:AMED) A Risky Investment?

Feb 20
Is Amedisys (NASDAQ:AMED) A Risky Investment?

Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Jan 19
Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

Dec 03
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Nov 18
These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely

Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Aug 18
Amedisys (NASDAQ:AMED) Could Easily Take On More Debt

Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Jul 23
Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)

Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity

Jul 18

Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

Jun 28
Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive

It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Jun 02
It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package

Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

May 24
Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?

株主還元

AMEDUS HealthcareUS 市場
7D-0.1%-1.2%-1.0%
1Y-4.0%2.5%30.3%

業界別リターン: AMED過去 1 年間で2.5 % の収益を上げたUS Healthcare業界を下回りました。

リターン対市場: AMEDは、過去 1 年間で30.3 % のリターンを上げたUS市場を下回りました。

価格変動

Is AMED's price volatile compared to industry and market?
AMED volatility
AMED Average Weekly Movement1.7%
Healthcare Industry Average Movement7.0%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

安定した株価: AMED過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: AMEDの 週次ボラティリティ ( 2% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
198219,000Richard Ashworthwww.amedisys.com

Amedisys, Inc.はその子会社とともに、米国でヘルスケア・サービスを提供している。3つのセグメントで事業を展開:在宅医療、ホスピス、高度急性期医療。在宅医療部門は、手術、慢性障害、終末期疾患からの回復、回避可能な再入院の予防のために、熟練した看護師、看護サービス、理学療法、言語療法、作業療法を専門とするリハビリ療法士、ソーシャルワーカーや介助員など、さまざまなサービスを個人の自宅で提供している。ホスピス部門は、がん、心臓病、肺疾患、アルツハイマー病などの終末期疾患を抱える人々に、安らぎとサポートを提供することを目的としたサービスを提供している。高度急性期医療部門は、入院患者、熟練看護師による看護、緩和ケアに不可欠な要素を在宅患者に提供する。アメディシス社は1982年に法人化され、ルイジアナ州バトンルージュに本社を置いている。

Amedisys, Inc. 基礎のまとめ

Amedisys の収益と売上を時価総額と比較するとどうか。
AMED 基礎統計学
時価総額US$2.95b
収益(TTM)US$82.93m
売上高(TTM)US$2.32b

35.6x

PER(株価収益率

1.3x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
AMED 損益計算書(TTM)
収益US$2.32b
売上原価US$1.31b
売上総利益US$1.01b
その他の費用US$930.68m
収益US$82.93m

直近の収益報告

Sep 30, 2024

次回決算日

該当なし

一株当たり利益(EPS)2.53
グロス・マージン43.67%
純利益率3.57%
有利子負債/自己資本比率29.4%

AMED の長期的なパフォーマンスは?

過去の実績と比較を見る